Therapeutic Classes/Tumor Necrosis Factor Blocker

Tumor Necrosis Factor Blocker

17 drugs across 8 manufacturers|1 Generic,16 Brand

The Tumor Necrosis Factor Blocker class contains 17 NDCs from 8 manufacturers (1 generic, 16 brand), at an average NADAC of $3610.25 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

1G / 16B

Manufacturers

Avg $3610.2460/unit

Avg 7d Change

+0.04%

Across 7 drugs with changes

7d Activity

4↑3↓10 flat

of 17 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Manufacturer Breakdown

8 manufacturers producing drugs in this therapeutic class

Janssen Biotech, Inc.

Coherus BioSciences Inc

1 drug

$604.1525

avg/unit

Meitheal Pharmaceuticals Inc.

Drug Portfolio

17 drugs total, 17 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Manufacturer ↕
SIMPONI 50 MG/0.5 ML SYRINGE golimumab	57894007001	$12977.2440 per ML	—	Brand	—	Janssen Biotech, Inc.
SIMPONI 50 MG/0.5 ML PEN INJEC golimumab	57894007002	$12890.3164 per ML	-0.15%	Brand	—	Janssen Biotech, Inc.
SIMPONI 100 MG/ML PEN INJECTOR golimumab	57894007102	$7446.2126 per ML	—	Brand	—	Janssen Biotech, Inc.
CIMZIA 2X200 MG/ML SYRINGE KIT certolizumab pegol	50474071079	$6094.0250 per EA	—	Brand	—	UCB, Inc.
CIMZIA 2X200 MG/ML(X3)START KT certolizumab pegol	50474071081	$6072.5137 per EA	—	Brand	—	UCB, Inc.
ENBREL 25 MG/0.5 ML SYRINGE etanercept	58406001004	$2084.1443 per ML	-0.10%	Brand	—	Immunex Corporation
ENBREL 50 MG/ML SURECLICK etanercept	58406003204	$2083.4784 per ML	-0.01%	Brand	—	Immunex Corporation
ENBREL 50 MG/ML MINI CARTRIDGE etanercept	58406004404	$2080.9950 per ML	—	Brand	—	Immunex Corporation
ENBREL 50 MG/ML SYRINGE etanercept	58406002104	$2080.5922 per ML	0.00%	Brand	—	Immunex Corporation
ADALIMUMAB-ADAZ(CF) PEN 40 MG/0.4 ML adalimumab-adaz	61314032720	$1587.8176 per ML	+0.07%	Generic	—	Sandoz Inc.
HADLIMA(CF) PUSHTOUCH 40 MG/0.4 ML adalimumab-bwwd	78206018701	$1259.1544 per ML	+0.03%	—	—	Organon LLC
HADLIMA(CF) 40 MG/0.4 ML SYRINGE adalimumab-bwwd	78206018601	$1258.3781 per ML	+0.30%	—	—	Organon LLC
REMICADE 100 MG VIAL INFLIXIMAB	57894003001	$1135.9660 per EA	—	Brand	—	Janssen Biotech, Inc.
HADLIMA PUSHTOUCH 40 MG/0.8 ML adalimumab-bwwd	78206018401	$623.4931 per ML	+0.12%	—	—	Organon LLC
YUSIMRY(CF) 40 MG/0.8 ML PEN adalimumab-aqvh	70114022002	$604.1525 per ML	—	—	—	Coherus BioSciences Inc
YUSIMRY(CF) 40 MG/0.8 ML PEN adalimumab-aqvh	71288081581	$604.1525 per ML	—	—	—	Meitheal Pharmaceuticals Inc.
INFLECTRA 100 MG VIAL infliximab-dyyb	00069080901	$491.5457 per EA	—	—	—	Pfizer Inc.

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Top supplier

Janssen Biotech, Inc. manufacturer profile

Review the supplier with the strongest product footprint inside this therapeutic class.

Lead market

etanercept market page

Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.

Trend hub

Latest trend hub

Compare this class against the rest of the weekly NADAC trend surface.

Guide

Understanding NADAC pricing

Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.

Frequently Asked Questions

How many drugs are in the Tumor Necrosis Factor Blocker class?

The Tumor Necrosis Factor Blocker class contains 17 NDCs from 8 manufacturers — 1 generic and 16 brand products.

What is the average price of Tumor Necrosis Factor Blocker drugs?

The average NADAC for the Tumor Necrosis Factor Blocker class is $3610.2460 per unit across 17 NDCs.

Is generic cheaper than brand in the Tumor Necrosis Factor Blocker class?

Among products priced per ML, the average generic NADAC in this class is $1587.8176, versus $3832.6928 for brand — brand products average about 2.4× the generic price.

Which manufacturers make Tumor Necrosis Factor Blocker drugs?

8 manufacturers make drugs in the Tumor Necrosis Factor Blocker class. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (4), Immunex Corporation (4), Organon LLC (3), UCB, Inc. (2), Sandoz Inc. (1).

How has Tumor Necrosis Factor Blocker pricing changed recently?

Over the past 7 days, 4 NDCs in this class rose and 3 fell, with a class-wide average change of +0.0%.